Cell Death Society Symposium on Targeting Cell Death Pathways for Human Diseases

描述（由申请人提供）：本申请要求资助将于2008年6月6日至9日在中国上海国家会计学院举行的细胞死亡国际会议。会议的主题是“靶向人类疾病的细胞死亡途径”。由于中国和日本的基础研究和针对性临床研究之间的密切互动，该场所特别适合作为美国科学家学习新方法并在广泛的兴趣范围内进行有效互动的场所。我们的会议将讨论细胞死亡的决定是如何被调节和触发的。这些主题对老年学、免疫学、神经学和肿瘤学领域特别感兴趣。考虑到这些因素以及对特定干预目标的需要，这是一个最有利的时机，可以将来自几个国家的基础研究人员、临床医生和制药研究人员聚集在一起。将有两个海报会议。通过在受邀演讲的战略要点上穿插从提交的摘要中选出的简短演讲，新兴科学家得到了很好的曝光。该日程安排是适应中国的习俗，并允许正式和非正式的讨论和社交的充足时间。我们会议的一个重要方面是总结谈话，总结主要的新发现，跟踪新兴趋势，并为未来趋势提供指导。我们的会议将讨论如何从基础研究到开发治疗干预方法和针对人类疾病的细胞死亡途径的想法。

DESCRIPTION (provided by applicant): This application requests funds to support the International Conference on Cell Death, to be held at Shanghai National Accounting Institute, Shanghai, China, June 6-9 2008. The theme of the conference will be "Targeting cell death pathways for human diseases". Because of the close interaction between basic research and targeted clinical research in China and Japan, this locale is particularly suitable as a site at which US scientists can learn new approaches and interact effectively across a broad spectrum of interests. Our meeting will address the means by which the decision of a cell to die is modulated and triggered. These topics are of particular interest to the fields of gerontology, immunology, neurology, and oncology. With these considerations as well as the need for specific targeting of intervention, this is a most propitious time to bring together basic researchers, clinicians, and pharmaceutical researchers from several nations. There will be two poster sessions. Emerging scientists are given good exposure by interspersing short talks, chosen from submitted abstracts, at strategic points among the invited talks. The schedule is adapted to the customs of China and allows ample time for formal and informal discussions and socializing. An important aspect of our meetings has been a wrap-up talk, which summarizes the major new findings, traces emerging trends, and provides guidance for future trends. Our meeting will address the idea of how to go from basic research to development of methods for therapeutic interventions and targeting cell death pathways for human diseases.